EA200800785A1 - 4-арил-1,4-дигидро-3(2н)-изохинолиноны и 4-арил-1,2,3,4-тетрагидроизохинолины в качестве ингибиторов igf-1r и в качестве фармакологического средства в тест-системах, фармацевтическая композиция и изделие на их основе и способ лечения заболеваний, опосредованных igf-1 рецептором - Google Patents
4-арил-1,4-дигидро-3(2н)-изохинолиноны и 4-арил-1,2,3,4-тетрагидроизохинолины в качестве ингибиторов igf-1r и в качестве фармакологического средства в тест-системах, фармацевтическая композиция и изделие на их основе и способ лечения заболеваний, опосредованных igf-1 рецепторомInfo
- Publication number
- EA200800785A1 EA200800785A1 EA200800785A EA200800785A EA200800785A1 EA 200800785 A1 EA200800785 A1 EA 200800785A1 EA 200800785 A EA200800785 A EA 200800785A EA 200800785 A EA200800785 A EA 200800785A EA 200800785 A1 EA200800785 A1 EA 200800785A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- aryl
- igf
- receptor
- izohinolinoniny
- tatarstan
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
- C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Синтезированы соединения формулы (I). Обнаружено, что они регулируют понижающим образом или ингибируют экспрессию или функцию рецептора IGF-1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IB2005002701 | 2005-09-09 | ||
PCT/IB2006/002473 WO2007029106A1 (en) | 2005-09-09 | 2006-09-08 | Isoquinolines as igf-1r inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200800785A1 true EA200800785A1 (ru) | 2008-08-29 |
Family
ID=36350070
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200800785A EA200800785A1 (ru) | 2005-09-09 | 2006-09-08 | 4-арил-1,4-дигидро-3(2н)-изохинолиноны и 4-арил-1,2,3,4-тетрагидроизохинолины в качестве ингибиторов igf-1r и в качестве фармакологического средства в тест-системах, фармацевтическая композиция и изделие на их основе и способ лечения заболеваний, опосредованных igf-1 рецептором |
Country Status (19)
Country | Link |
---|---|
US (1) | US8044067B2 (ru) |
EP (1) | EP1931636B1 (ru) |
JP (1) | JP2009507819A (ru) |
KR (1) | KR20080042897A (ru) |
CN (1) | CN101258130B (ru) |
AT (1) | ATE505457T1 (ru) |
AU (1) | AU2006288846B2 (ru) |
BR (1) | BRPI0616732A2 (ru) |
CA (1) | CA2621836C (ru) |
DE (1) | DE602006021327D1 (ru) |
DK (1) | DK1931636T3 (ru) |
EA (1) | EA200800785A1 (ru) |
ES (1) | ES2364673T3 (ru) |
HK (1) | HK1115500A1 (ru) |
IL (1) | IL189883A (ru) |
NO (1) | NO20081207L (ru) |
NZ (1) | NZ566524A (ru) |
WO (1) | WO2007029106A1 (ru) |
ZA (1) | ZA200801875B (ru) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011112666A1 (en) | 2010-03-09 | 2011-09-15 | OSI Pharmaceuticals, LLC | Combination anti-cancer therapy |
EP2671082B1 (en) | 2011-02-02 | 2020-01-15 | Amgen Inc. | Methods and compositons relating to inhibition of igf-1r |
US20140046059A1 (en) * | 2011-04-21 | 2014-02-13 | Piramal Enterprises Limited | Process for the preparation of morpholino sulfonyl indole derivatives |
EP2776042B1 (en) | 2011-11-11 | 2019-03-20 | Duke University | Combination drug therapy for the treatment of solid tumors |
US8980259B2 (en) | 2012-07-20 | 2015-03-17 | Novartis Ag | Combination therapy |
CN104672136B (zh) * | 2013-11-30 | 2017-01-25 | 沈阳药科大学 | 1‑取代菲基‑n‑烷基(酰基)‑6,7‑二甲氧基‑1,2,3,4‑四氢异喹啉衍生物及其制备方法和用途 |
WO2017129763A1 (en) | 2016-01-28 | 2017-08-03 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of signet ring cell gastric cancer |
EP3941905A1 (en) * | 2019-03-19 | 2022-01-26 | Suvalent Therapeutics, Inc. | Sumo inhibitor compounds and uses thereof |
CN114456184B (zh) * | 2022-02-21 | 2023-08-22 | 南华大学附属第一医院 | 一种3-芳基异喹啉衍生物及其制备与应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100878855B1 (ko) * | 1999-11-03 | 2009-01-15 | 에이엠알 테크놀로지, 인크. | 4-페닐-치환 테트라히드로이소퀴놀린, 및 노르에피네프린과 도파민과 세로토닌의 재흡수를 차단하기 위한 이의 용도 |
SE0203746D0 (sv) * | 2002-12-18 | 2002-12-18 | Karolinska Innovations Ab | New compounds |
ES2299825T3 (es) * | 2004-03-12 | 2008-06-01 | Analytecon S.A. | Derivados de tetrahidroisoquinoleino y de tetrahidrobenzazepina utilizados como inhibidores de igf-1r. |
-
2006
- 2006-09-08 NZ NZ566524A patent/NZ566524A/en not_active IP Right Cessation
- 2006-09-08 WO PCT/IB2006/002473 patent/WO2007029106A1/en active Application Filing
- 2006-09-08 AT AT06795448T patent/ATE505457T1/de not_active IP Right Cessation
- 2006-09-08 BR BRPI0616732-2A patent/BRPI0616732A2/pt active Search and Examination
- 2006-09-08 EA EA200800785A patent/EA200800785A1/ru unknown
- 2006-09-08 KR KR1020087006671A patent/KR20080042897A/ko not_active Application Discontinuation
- 2006-09-08 CA CA2621836A patent/CA2621836C/en not_active Expired - Fee Related
- 2006-09-08 JP JP2008529710A patent/JP2009507819A/ja active Pending
- 2006-09-08 EP EP06795448A patent/EP1931636B1/en active Active
- 2006-09-08 CN CN2006800329830A patent/CN101258130B/zh not_active Expired - Fee Related
- 2006-09-08 DK DK06795448.7T patent/DK1931636T3/da active
- 2006-09-08 AU AU2006288846A patent/AU2006288846B2/en not_active Ceased
- 2006-09-08 DE DE602006021327T patent/DE602006021327D1/de active Active
- 2006-09-08 ES ES06795448T patent/ES2364673T3/es active Active
- 2006-09-08 US US11/991,431 patent/US8044067B2/en not_active Expired - Fee Related
-
2008
- 2008-02-28 ZA ZA200801875A patent/ZA200801875B/xx unknown
- 2008-03-02 IL IL189883A patent/IL189883A/en not_active IP Right Cessation
- 2008-03-07 NO NO20081207A patent/NO20081207L/no not_active Application Discontinuation
- 2008-09-29 HK HK08110849.4A patent/HK1115500A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ZA200801875B (en) | 2009-08-26 |
NO20081207L (no) | 2008-05-27 |
DK1931636T3 (da) | 2011-07-25 |
HK1115500A1 (en) | 2008-11-28 |
WO2007029106A1 (en) | 2007-03-15 |
IL189883A (en) | 2012-07-31 |
CA2621836C (en) | 2013-11-12 |
DE602006021327D1 (de) | 2011-05-26 |
AU2006288846B2 (en) | 2011-08-18 |
ATE505457T1 (de) | 2011-04-15 |
US20090099229A1 (en) | 2009-04-16 |
IL189883A0 (en) | 2008-11-03 |
EP1931636A1 (en) | 2008-06-18 |
CN101258130A (zh) | 2008-09-03 |
EP1931636B1 (en) | 2011-04-13 |
BRPI0616732A2 (pt) | 2013-01-01 |
KR20080042897A (ko) | 2008-05-15 |
ES2364673T3 (es) | 2011-09-12 |
AU2006288846A1 (en) | 2007-03-15 |
CN101258130B (zh) | 2012-11-28 |
CA2621836A1 (en) | 2007-03-15 |
JP2009507819A (ja) | 2009-02-26 |
NZ566524A (en) | 2011-01-28 |
US8044067B2 (en) | 2011-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200800785A1 (ru) | 4-арил-1,4-дигидро-3(2н)-изохинолиноны и 4-арил-1,2,3,4-тетрагидроизохинолины в качестве ингибиторов igf-1r и в качестве фармакологического средства в тест-системах, фармацевтическая композиция и изделие на их основе и способ лечения заболеваний, опосредованных igf-1 рецептором | |
NL300933I2 (nl) | Letermovir | |
BRPI0417543A (pt) | quinolinas úteis no tratamento de doença cardiovascular | |
ATE440087T1 (de) | 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen | |
NO20054404L (no) | 5,7-Diaminopyrazolo [4,3-D] Pyrimidiner Anvendelige ved behandling av of Hypertensjon | |
CY1114095T1 (el) | Μυκητοκτονες συνθεσεις | |
RS20050769A (en) | Derivatives of 2-acylamino-4- phenylthiazole,preparation method thereof and application of same in therapeutics | |
WO2007038571A3 (en) | Prolyl hydroxylase antagonists | |
UA83875C2 (ru) | Производные хинолина для применения в качестве микобактериальных ингибиторов | |
CR6540A (es) | Trifluorobutenos nematicidas | |
MY141972A (en) | Biaryloxymethylarenecarboxylic acids | |
EA200602196A1 (ru) | Производные пиразола, композиции, содержащие эти соединения, и способы применения | |
NO20055516L (no) | Kannabinoidreceptorligander og anvendelser derav | |
NO20062256L (no) | Hydroksyalkylsubstituerte pyrido-7-pyrimidin-7-oner | |
BRPI0413973A (pt) | compostos | |
TW200633977A (en) | Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives | |
DE60307268D1 (de) | Pestizide pyridincarbonsäureamidderivate | |
DE602005020185D1 (de) | Verfahren zur herstellung von 17-hydroxy-6 beta, 7 beta, 15 beta,16 beta-bismethylen-17alpha-pregn-4henprodukte für dieses verfahren | |
WO2007017511A3 (de) | Verbindungen zur behandlung der alzheimer erkrankung | |
EA200700550A1 (ru) | Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств | |
ATE476419T1 (de) | Isochinolinon-kaliumkanalinhibitoren | |
SE0200844D0 (sv) | Chemical compounds | |
WO2004099388A3 (en) | Cbl-b polypeptides, complexes and related methods | |
ATE407126T1 (de) | Herstellung von (s)-4-fluormethyl-dihydro-furan-2-on | |
ATE335739T1 (de) | Cak inhibitoren und deren verwendungen |